SC panel member urges CJI to release farm laws report

The report can... play an educational role and ease the misapprehensions of many farmers who have, in my opinion, been misguided ANIL GHANWAT, SC panel on farm laws

NEW DELHI: Anil Ghanwat, one of the members of the Supreme Court-appointed panel on farm laws, on Tuesday wrote to Chief Justice of India (CJI) urging him to consider releasing the report on the three agri laws in the public domain at the earliest or authorise the committee to do so.

Ghanwat, also a senior leader of Shetkari Sangathan, separately in a media briefing said he will mobilise 100,000 farmers to Delhi in the next couple of months demanding “badly” required agri reforms even after the repeal of the three farm laws. He also said the protesting farmers’ demand to make minimum support price (MSP) a legal guarantee and ensure procurement of all agri-crops at MSP is “not feasible and implementable”.

In the letter dated November 23 written to CJI NV Ramana,

Ghanwat said after the government’s decision to repeal the three farm laws in the coming Winter Session of Parliament, the panel’s report is “no longer relevant” but the recommendations are of great public interest.

“It’s been over eight months since the report has been submitted. Now the laws are going to be repealed, at least the report should be made available to the public so that people know the recommendations,” he said.

“The report can also play an educational role and ease the misapprehensions of many farmers who have, in my opinion, been misguided by some leaders .... ,” he added.

NEW DELHI: The efficacy of Covaxin to prevent symptomatic Covid-19 dropped to 47%-50%, according to real-world data derived from infections in a group of over 2,700 hospital workers when India was hit by the Delta variant, according to a study published on Tuesday in the journal Lancet Infectious Diseases.

The findings are based on a phase 3 randomised control trial carried out between April 15 and May 15, at the height of India’s second wave of infections. All vaccines have shown to be less effective when infections have been caused by the more transmissible variant of the SarsCoV-2, and the latest report underscores the higher odds of catching Covid-19 during an active wave and among healthcare workers. “…The adjusted effectiveness of BBV152 against symptomatic COVID-19 after two doses administered at least 14 days before testing was 50%... The adjusted effectiveness of two doses administered at least 28 days before testing was 46%,” said the study.

member,